Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|January 14, 2025
Novel mechanisms of resistance in CLL: variant BTK mutations in second-generation and noncovalent BTK inhibitorsConstantine S Tam, Shalini Balendran, Piers Blombery
Blood|April 4, 2020
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclaxVictor S Lin, Thomas E Lew, Sasanka M Handunnetti, et al.
Blood|January 28, 2017
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromesPaul Yeh, Michael Dickinson, Sarah Ftouni, et al.
Blood|December 8, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, et al.
Blood|October 26, 2023
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC studyAdrian Minson, Nada Hamad, Chan Y Cheah, et al.
Blood|September 1, 2021
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLLPiers Blombery, Thomas E Lew, Michael A Dengler, et al.
Blood|May 11, 2021
Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cellsKenneth P Micklethwaite, Kavitha Gowrishankar, Brian S Gloss, et al.
Blood|June 16, 2022
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapyRachel Thijssen, Luyi Tian, Mary Ann Anderson, et al.
Blood|October 11, 2022
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemiaDonia M Moujalled, Fiona C Brown, Chong Chyn Chua, et al.
Blood|January 13, 2026
The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic LeukemiaOthman Al-Sawaf, Benjamin Nick Locher, Friederike Christen, et al.
Pageof 2